BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24086362)

  • 1. Reduced mitochondrial DNA content associates with poor prognosis of prostate cancer in African American men.
    Koochekpour S; Marlowe T; Singh KK; Attwood K; Chandra D
    PLoS One; 2013; 8(9):e74688. PubMed ID: 24086362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dysfunction and prostate cancer racial disparities among American men.
    Chaudhary AK; O'Malley J; Kumar S; Inigo JR; Kumar R; Yadav N; Chandra D
    Front Biosci (Schol Ed); 2017 Jan; 9(1):154-164. PubMed ID: 27814581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison.
    Ritch CR; Morrison BF; Hruby G; Coard KC; Mayhew R; Aiken W; Benson MC; McKiernan JM
    BJU Int; 2013 Apr; 111(4 Pt B):E186-90. PubMed ID: 23107067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the aggressiveness of prostate cancer among Korean, Caucasian, and African American men: A retrospective cohort study of radical prostatectomy.
    Jeong IG; Dajani D; Verghese M; Hwang J; Cho YM; Hong JH; Kim CS; Ahn H; Ro JY
    Urol Oncol; 2016 Jan; 34(1):3.e9-14. PubMed ID: 26345648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct Genomic Alterations in Prostate Tumors Derived from African American Men.
    Liu W; Zheng SL; Na R; Wei L; Sun J; Gallagher J; Wei J; Resurreccion WK; Ernst S; Sfanos KS; Isaacs WB; Xu J
    Mol Cancer Res; 2020 Dec; 18(12):1815-1824. PubMed ID: 33115829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. African-American men with nonpalpable prostate cancer exhibit greater tumor volume than matched white men.
    Sanchez-Ortiz RF; Troncoso P; Babaian RJ; Lloreta J; Johnston DA; Pettaway CA
    Cancer; 2006 Jul; 107(1):75-82. PubMed ID: 16736511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered mitochondrial genome content signals worse pathology and prognosis in prostate cancer.
    Kalsbeek AMF; Chan EKF; Grogan J; Petersen DC; Jaratlerdsiri W; Gupta R; Lyons RJ; Haynes AM; Horvath LG; Kench JG; Stricker PD; Hayes VM
    Prostate; 2018 Jan; 78(1):25-31. PubMed ID: 29134670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum of mitochondrial genomic variation and associated clinical presentation of prostate cancer in South African men.
    McCrow JP; Petersen DC; Louw M; Chan EK; Harmeyer K; Vecchiarelli S; Lyons RJ; Bornman MS; Hayes VM
    Prostate; 2016 Mar; 76(4):349-58. PubMed ID: 26660354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High circulating estrogens and selective expression of ERβ in prostate tumors of Americans: implications for racial disparity of prostate cancer.
    Abd Elmageed ZY; Moroz K; Srivastav SK; Fang Z; Crawford BE; Moparty K; Thomas R; Abdel-Mageed AB
    Carcinogenesis; 2013 Sep; 34(9):2017-23. PubMed ID: 23658372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location.
    Faisal FA; Sundi D; Tosoian JJ; Choeurng V; Alshalalfa M; Ross AE; Klein E; Den R; Dicker A; Erho N; Davicioni E; Lotan TL; Schaeffer EM
    Eur Urol; 2016 Jul; 70(1):14-17. PubMed ID: 26443432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian men.
    Kwabi-Addo B; Wang S; Chung W; Jelinek J; Patierno SR; Wang BD; Andrawis R; Lee NH; Apprey V; Issa JP; Ittmann M
    Clin Cancer Res; 2010 Jul; 16(14):3539-47. PubMed ID: 20606036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial Difference in Prostate Cancer Cell Telomere Lengths in Men with Higher Grade Prostate Cancer: A Clue to the Racial Disparity in Prostate Cancer Outcomes.
    Heaphy CM; Joshu CE; Barber JR; Davis C; Zarinshenas R; De Marzo AM; Lotan TL; Sfanos KS; Meeker AK; Platz EA
    Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):676-680. PubMed ID: 31915143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. African-American men with prostate cancer have larger tumor volume than Caucasian men despite no difference in serum prostate specific antigen.
    Fuletra JG; Kamenko A; Ramsey F; Eun DD; Reese AC
    Can J Urol; 2018 Feb; 25(1):9193-9198. PubMed ID: 29524974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copy number and gene expression differences between African American and Caucasian American prostate cancer.
    Rose AE; Satagopan JM; Oddoux C; Zhou Q; Xu R; Olshen AB; Yu JZ; Dash A; Jean-Gilles J; Reuter V; Gerald WL; Lee P; Osman I
    J Transl Med; 2010 Jul; 8():70. PubMed ID: 20649978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial DNA in serum of patients with prostate cancer: a predictor of biochemical recurrence after prostatectomy.
    Ellinger J; Müller SC; Wernert N; von Ruecker A; Bastian PJ
    BJU Int; 2008 Aug; 102(5):628-32. PubMed ID: 18410441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial DNA copy number in peripheral blood leukocytes is associated with biochemical recurrence in prostate cancer patients in African Americans.
    Xu J; Chang WS; Tsai CW; Bau DT; Davis JW; Thompson TC; Logothetis CJ; Gu J
    Carcinogenesis; 2020 May; 41(3):267-273. PubMed ID: 31408512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-Identified African Americans and prostate cancer risk: West African genetic ancestry is associated with prostate cancer diagnosis and with higher Gleason sum on biopsy.
    Grizzle WE; Kittles RA; Rais-Bahrami S; Shah E; Adams GW; DeGuenther MS; Kolettis PN; Nix JW; Bryant JE; Chinsky R; Kearns JE; Dehimer K; Terrin N; Chang H; Gaston SM
    Cancer Med; 2019 Nov; 8(16):6915-6922. PubMed ID: 31568648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population.
    Petrovics G; Price DK; Lou H; Chen Y; Garland L; Bass S; Jones K; Kohaar I; Ali A; Ravindranath L; Young D; Cullen J; Dorsey TH; Sesterhenn IA; Brassell SA; Rosner IL; Ross D; Dahut W; Ambs S; Figg WD; Srivastava S; Dean M
    Prostate Cancer Prostatic Dis; 2019 Sep; 22(3):406-410. PubMed ID: 30542053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men.
    Petrovics G; Li H; Stümpel T; Tan SH; Young D; Katta S; Li Q; Ying K; Klocke B; Ravindranath L; Kohaar I; Chen Y; Ribli D; Grote K; Zou H; Cheng J; Dalgard CL; Zhang S; Csabai I; Kagan J; Takeda D; Loda M; Srivastava S; Scherf M; Seifert M; Gaiser T; McLeod DG; Szallasi Z; Ebner R; Werner T; Sesterhenn IA; Freedman M; Dobi A; Srivastava S
    EBioMedicine; 2015 Dec; 2(12):1957-64. PubMed ID: 26844274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistological analysis of ABCD3 expression in Caucasian and African American prostate tumors.
    Reams RR; Jones-Triche J; Chan OT; Hernandez BY; Soliman KF; Yates C
    Biomed Res Int; 2015; 2015():132981. PubMed ID: 25802834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.